equin
influenza
ei
caus
equin
influenza
viru
eiv
one
import
respiratori
diseas
hors
due
highli
contagi
eiv
member
famili
orthomyxovirida
genu
influenza
viru
although
two
subtyp
eiv
recogn
virus
subtyp
isol
last
three
decad
may
contrast
virus
subtyp
major
caus
respiratori
diseas
hors
throughout
world
except
equin
popul
new
zealand
iceland
ei
never
hors
infect
eiv
exhibit
acut
onset
pyrexia
associ
depress
anorexia
nasal
discharg
eiv
infect
occur
via
inhal
aerosol
viru
particl
way
human
season
presumpt
diagnosi
ei
made
group
suscept
hors
basi
rapid
spread
febril
diseas
frequent
howev
clinic
sever
rapid
diseas
spread
depend
immun
statu
herd
difficult
distinguish
ei
vaccin
hors
acut
respiratori
diseas
exampl
equin
rhinopneumon
equin
viral
arter
equin
rhiniti
viru
thu
laboratori
test
identifi
eiv
respiratori
tract
secret
detect
seroconvers
requir
make
definit
diagnosi
viru
isol
vi
tradit
gold
standard
diagnost
method
replac
revers
transcriptas
polymeras
chain
reaction
assay
superior
rapid
also
rapid
antigen
detect
rad
test
licens
diagnos
human
influenza
success
use
diagnosi
rad
test
enabl
qualit
detect
influenza
viral
nucleoprotein
antigen
respiratori
specimen
without
technic
expertis
expens
thu
often
use
initi
screen
test
varieti
rad
test
commerci
time
write
april
least
rad
test
commerci
avail
japan
diagnos
human
influenza
one
rad
kit
diagnosi
avian
influenza
prior
one
conduct
extens
comparison
sensit
rad
test
detect
eiv
evalu
sensit
select
rad
test
licens
japan
diagnosi
human
avian
influenza
detect
eiv
nasopharyng
swab
experiment
natur
infect
hors
eiv
strain
propag
allanto
caviti
embryon
hen
egg
stock
viru
subject
centrifug
g
min
remov
cell
debri
aliquot
store
use
stock
viru
titr
egg
infecti
dose
ml
viru
challeng
carri
previous
three
hors
inocul
inhal
mlhead
day
nasopharyng
swab
jcb
industri
tokyo
japan
collect
daili
day
day
follow
collect
swab
place
ml
transport
medium
salin
supplement
wv
tryptos
phosphat
broth
unitsml
penicillin
streptomycin
amphotericin
b
nasopharyng
swab
transport
medium
subsequ
vortex
second
centrifug
g
min
supernat
aliquot
store
use
viru
isol
vi
conduct
previous
experiment
protocol
approv
anim
care
committe
equin
research
institut
japan
race
associ
thirti
nasopharyng
sampl
collect
ei
outbreak
ireland
analys
sampl
collect
hors
mix
vaccin
statu
varieti
premis
includ
polo
yard
n
three
race
yard
n
yard
n
show
jump
yard
n
thoroughbr
stud
n
stud
n
follow
sampl
collect
nasopharyng
swab
place
ml
transport
medium
carri
previous
thirti
nasopharyng
sampl
also
collect
racehors
japan
rad
test
includ
studi
purchas
commerci
tabl
rad
test
licens
diagnosi
human
avian
influenza
esplin
influenza
japan
test
conduct
accord
manufactur
instruct
initi
test
determin
detect
limit
rad
conduct
duplic
use
fivefold
serial
dilut
viru
stock
transport
medium
evalu
conduct
rad
test
lowest
limit
detect
use
nasopharyng
swab
collect
experiment
infect
natur
infect
hors
result
judg
two
oper
posit
band
visibl
examin
approx
cm
eye
sampl
assign
score
posit
posit
band
visibl
examin
sampl
deem
neg
case
judgement
split
sampl
assign
detect
limit
express
minimum
viru
titr
posit
reaction
viral
rna
extract
stockdilut
virus
clinic
sampl
magna
pure
lc
total
nucleic
acid
isol
test
roch
diagnost
tokyo
japan
magna
pure
lc
system
roch
diagnost
per
manufactur
instruct
extract
rna
elut
final
volum
primer
hemagglutinin
ha
conduct
use
qiagen
onestep
kit
qiagen
tokyo
japan
describ
primer
probe
ha
perform
use
taqman
fast
viru
master
mix
life
technolog
japan
tokyo
japan
accord
manufactur
instruct
thermal
cycl
condit
follow
initi
hold
min
second
cycl
second
second
quantifi
copi
number
eiv
artifici
rna
synthes
describ
initi
dna
fragment
ha
gene
amplifi
use
primer
set
describ
newton
et
amplifi
product
use
templat
second
pcr
second
pcr
perform
use
modifi
forward
primer
contain
promot
sequenc
revers
primer
rna
synthes
use
rna
polymeras
treat
dnase
roch
diagnost
copi
number
rna
calcul
absorb
valu
nm
result
posit
averag
copi
number
exceed
rna
moleculesreact
copiesml
start
sampl
isotherm
amplif
conduct
use
loopamp
rna
amplif
kit
eiken
chemic
tokyo
japan
previous
three
test
also
use
determin
detect
limit
mention
averag
detect
period
analys
analysi
varianc
post
hoc
method
use
sigmaplot
systat
softwar
san
jose
ca
usa
level
p
consid
signific
analysi
perform
rad
test
clinic
sampl
sensit
specif
kappa
coeffici
valu
calcul
use
excel
microsoft
japan
tokyo
japan
kappa
coeffici
valu
evalu
accord
guidelin
mention
landi
follow
agreement
slight
fair
moder
substanti
almost
perfect
agreement
use
viral
rna
detect
limit
molecular
test
convent
eiv
respect
comparison
detect
limit
rad
test
eiv
shown
tabl
detect
limit
four
test
immunoac
flu
bd
flu
examan
quick
chaser
flu
b
esplin
influenza
detect
limit
prime
check
clearview
exact
influenza
b
poctem
influenza
detect
limit
gold
sign
flu
clearlin
influenza
ab
quickvu
rapid
sp
influ
detect
eiv
undilut
stock
viru
detect
limit
twelv
test
four
sensit
rad
test
prorast
flu
exampl
rad
evalu
ei
experiment
infect
studi
diagnost
sensit
compar
vi
molecular
diagnost
assay
result
obtain
differ
assay
sequenti
sampl
collect
hors
experiment
infect
summar
tabl
averag
detect
period
assay
illustr
figur
mean
durat
day
posit
result
significantli
longer
rad
test
p
mean
durat
result
significantli
longer
rad
test
p
except
immunoac
flu
p
quick
chaser
flu
b
p
mean
durat
convent
result
significantli
longer
rad
test
p
except
immunoac
flu
p
quick
chaser
flu
b
p
mean
durat
posit
prorast
flu
result
significantli
shorter
test
studi
p
signific
differ
mean
durat
posit
result
obtain
molecular
assay
p
evalu
perform
sensit
rad
test
diagnos
ei
field
sampl
summar
tabl
nasopharyng
sampl
neg
rad
test
sampl
bd
flu
examan
detect
quick
chaser
flu
b
immunoac
flu
detect
posit
esplin
influenza
less
sensit
detect
eight
posit
sampl
kappa
coeffici
valu
indic
substanti
agreement
bd
flu
examan
quick
chaser
flu
b
immunoac
flu
fair
agreement
esplin
influenza
rapid
diagnosi
isol
hors
eiv
effect
measur
reduct
diseas
spread
isol
hors
play
key
role
minim
spread
ei
outbreak
rad
test
conduct
use
esplin
influenza
basi
previou
report
indic
compar
sensit
esplin
influenza
bd
directigen
flu
ab
detect
howev
esplin
influenza
modifi
bd
directigen
flu
ab
replac
new
product
bd
flu
examan
japan
bd
directigen
ez
flu
ab
best
knowledg
studi
first
comprehens
evalu
rad
test
current
market
et
report
differ
sensit
among
rad
test
detect
avian
likewis
studi
detect
limit
rad
test
evalu
vari
two
detect
eiv
undilut
stock
viru
four
rad
test
immunoac
flu
bd
flu
examan
quick
chaser
flu
b
esplin
influenza
commerci
avail
abl
detect
eiv
indic
import
select
suitabl
rad
test
screen
ei
find
support
result
experiment
infect
studi
summar
tabl
studi
fivefold
differ
detect
limit
prorast
flu
four
rad
test
immunoac
flu
bd
flu
examan
quick
chaser
flu
b
esplin
influenza
result
result
prorast
flu
failur
detect
ei
major
posit
nasopharyng
sampl
especi
day
immunoac
flu
bd
flu
examan
quick
chaser
flu
b
esplin
influenza
perform
well
indic
use
rad
diagnosi
ei
immunolog
hors
typic
miss
detect
viru
first
day
three
hors
posit
molecular
test
viru
isol
howev
point
time
hors
show
clinic
sign
therefor
test
due
suspicion
ei
sampl
would
collect
day
first
day
clinic
sign
day
associ
four
rad
test
success
detect
viru
hors
day
last
day
rad
test
posit
sampl
also
cultur
neg
day
rad
test
use
confirm
clinic
diagnosi
hors
like
tradit
guidelin
week
complet
rest
everi
day
increas
would
follow
hors
isol
hors
case
fact
rad
test
less
sensit
detect
viru
day
would
major
practic
implic
furthermor
differ
specif
four
rad
test
indic
low
risk
result
although
immunoac
flu
bd
flu
examan
quick
chaser
flu
b
esplin
influenza
show
highest
sensit
detect
limit
among
rad
test
sensit
lower
molecular
diagnos
larg
differ
sensit
rad
test
molecular
test
indic
latter
appropri
test
ei
diagnosi
howev
esplin
influenza
bd
directigen
flu
ab
use
screen
hors
quarantin
station
identif
infect
hors
ei
sensit
rad
test
may
serv
adjunct
molecular
test
posit
result
instruct
specif
test
rapid
easi
way
carri
preliminari
screen
ei
suspect
best
use
popul
hors
rather
individu
case
neg
test
result
need
verifi
molecular
test
thu
rad
test
unsuit
test
freedom
infect
prior
movement
decad
rapid
intern
movement
hors
air
increas
risk
viru
incurs
suscept
therefor
detect
hors
quarantin
facil
import
control
measur
test
need
optimum
sensit
major
hors
immun
day
shipment
either
primari
cours
booster
thu
like
shed
far
less
viru
hors
experiment
studi
discuss
may
show
clinic
sign
furthermor
quarantin
period
vari
depend
import
countri
purpos
movement
statu
export
countri
thu
window
opportun
detect
ei
may
quit
short
nasal
swab
may
collect
prior
viru
shed
peak
result
suggest
molecular
diagnosi
eiv
like
protect
suscept
local
popul
intrus
eiv
relianc
rad
test
less
sensit
molecular
test
use
studi
appear
sensit
assay
detect
limit
convert
approx
assum
effici
rna
extract
rad
test
enabl
veterinarian
other
respons
health
hors
perform
rapid
diagnosi
ei
without
special
equip
technic
expertis
howev
usag
even
sensit
rad
test
best
limit
popul
screen
neg
sampl
suspect
case
submit
laboratori
test
summari
result
studi
indic
sensit
rad
test
commerci
avail
japan
detect
eiv
vari
huge
moreov
studi
show
three
rad
test
name
immunoac
flu
bd
flu
examan
quick
chaser
flu
b
substanti
fit
diagnos
ei
viral
nucleoprotein
highli
conserv
last
three
decad
amino
acid
homolog
data
shown
eiv
sequenc
divers
affect
sensit
rad
test
howev
test
frequent
modifi
avail
vari
countri
countri
perform
may
period
requir
countri
rad
test
necessarili
perform
equin
healthcar
profession
essenti
respons
screen
hors
made
awar
major
test
unsuit
detect
hors
imper
select
appropri
rad
submit
neg
sampl
suspect
case
laboratori
confirmatori
test
author
declar
compet
interest
